Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y000224 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y011019 | — |
aMedical Assistant calling to report adverse event regarding MMR II and VARIVAX. Medical Assistant stated that a patient was administered doses of MMR II and VARIVAX after the vaccines have been reconstituted and drawn into a syringe and left out at; any medical concerns or symptoms after the administration of the improperly stored vaccines/No additional AE; This spontaneous report was received from a medical assistant and refers to a patient of a not reported age or gender. The patient's medical history, concurrent conditions, previous drugs reactions or allergies and concomitant therapies were not reported. On an unknown date (reported as 27-JAN-2026 conflicting information), the patient was vaccinated with an improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) injection, 0.5 ml / two dose series, lot# reported as Y000224 (which upon internal validation was found as valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)), expiration date reported as: 03-JAN-2026, administered for prophylaxis (strength, and route of administration were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 ml / two dose series, lot #Y011019, expiration date: 18-JUN-2026, administered for prophylaxis (strength, and route of administration were not provided) following a temperature excursion for over 1 hour and 30 minutes while unprotected from light.. Medical Assistant confirmed the patient involved has not reported any medical concerns or symptoms after the administration of the improperly stored vaccines.